Inovio Pharmaceuticals, Inc. (INO)
Largest Insider Buys in Sector
INO Stock Price History Chart
INO Stock Performance
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA …
Insider Activity of Inovio Pharmaceuticals, Inc.
Over the last 12 months, insiders at Inovio Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Inovio Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Inovio Pharmaceuticals, Inc. have bought $0 and sold $2.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 22,500 shares for transaction amount of $69,975 was made by Kim Jong Joseph (Chief Executive Officer) on 2020‑01‑13.
List of Insider Buy and Sell Transactions, Inovio Pharmaceuticals, Inc.
| 2023-06-05 | Sale | director | 5,700 0.0021% | $0.56 | $3,192 | -10.53% | ||
| 2023-03-13 | Sale | director | 5,833 0.0022% | $1.15 | $6,708 | -57.50% | ||
| 2023-02-27 | Sale | director | 11,668 0.0047% | $1.28 | $14,935 | -58.87% | ||
| 2022-08-11 | Sale | 11,875 0.0051% | $2.66 | $31,588 | -37.80% | |||
| 2022-07-20 | Sale | 2,000 0.0008% | $2.25 | $4,500 | -26.91% | |||
| 2022-05-13 | Sale | 9,000 0.0037% | $1.95 | $17,550 | -11.06% | |||
| 2022-05-13 | Sale | 3,600 0.0015% | $1.98 | $7,128 | -11.06% | |||
| 2022-03-16 | Sale | 2,000 0.0009% | $3.16 | $6,320 | -42.12% | |||
| 2022-03-11 | Sale | 4,083 0.0019% | $3.20 | $13,066 | -40.53% | |||
| 2022-03-08 | Sale | 4,083 0.0019% | $3.33 | $13,596 | -40.80% | |||
| 2022-01-19 | Sale | director | 2,000 0.0009% | $4.27 | $8,540 | -49.88% | ||
| 2022-01-05 | Sale | director | 961 0.0005% | $5.01 | $4,815 | -54.39% | ||
| 2021-08-09 | Sale | Chief Scientific Officer | 10,317 0.0047% | $9.15 | $94,401 | -60.42% | ||
| 2021-06-09 | Sale | CFO | 33,750 0.0161% | $10.01 | $337,838 | -37.39% | ||
| 2021-06-09 | Sale | Chief Scientific Officer | 10,318 0.0045% | $9.07 | $93,584 | -37.39% | ||
| 2021-06-09 | Sale | Chief Operating Officer | 38,535 0.0184% | $10.01 | $385,735 | -37.39% | ||
| 2021-06-03 | Sale | CFO | 10,000 0.0049% | $8.03 | $80,300 | -17.24% | ||
| 2021-05-17 | Sale | director | 3,045 0.0014% | $6.62 | $20,158 | 0.00% | ||
| 2021-05-17 | Sale | director | 3,045 0.0014% | $6.62 | $20,158 | 0.00% | ||
| 2021-05-17 | Sale | director | 2,045 0.001% | $6.62 | $13,538 | 0.00% |
Insider Historical Profitability
| Kim Jong Joseph | Chief Executive Officer | 1078313 2.987% | $1.84 | 17 | 13 | +45.41% |
| DHILLON AVTAR S | Executive Chairman | 233332 0.6463% | $1.84 | 2 | 0 | <0.0001% |
| KIES PETER | CFO | 130788 0.3623% | $1.84 | 5 | 10 | +7.37% |
| BENITO SIMON X | 75305 0.2086% | $1.84 | 2 | 11 | <0.0001% | |
| Humeau Laurent | Chief Scientific Officer | 68587 0.19% | $1.84 | 2 | 5 | +94.39% |